Bragar Eagle & Squire, PC examines compass,

Bragar Eagle & Squire, PC examines compass,


NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. (NYSE: CMP), EyePoint Pharmaceuticals, Inc (NASDAQ: EYPT), Q45 Training Holdings, Inc. (NYSE: FXLV) and PROG Holdings, Inc. (NYSE: PRG). Our investigations address whether these companies have violated federal securities laws and/or engaged in other illegal business practices. For more information on each case, see the link provided.

Compass Minerals International, Inc. (NYSE:CMP)

On September 23, 2022, the United States Securities and Exchange Commission (“SEC”) announced that Compass was ordered to pay $12 million to settle “misleading investor” fees by repeatedly asserting that a technology update at its flagship salt mine, “on track to significantly reduce costs and improve operating results beginning in 2018” when in reality costs at the mine “increased significantly [undermining] the projected savings.” Additionally, the SEC also found that Compass had overstated the amount of salt it could produce.

On the news, Compass stock fell $1.58, or 4.1%, to close at $36.88 per share on September 23, 2022.

For more information on the Compass investigation, visit:

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

On August 30, 2022, after the market close, EyePoint announced that it had received a subpoena from the United States Attorney for the District of Massachusetts. The subpoena requested documents covering the company’s sales practices for its post-surgical inflammation treatment DEXYCU.

As a result of this news, EyePoint stock fell $0.21 per share, or 2%, to close at $10.00 per share on August 31, 2022.

For more information on the EyePoint exam, visit:

F45 Training Holdings, Inc. (NYSE:FXLV)

On or about July 15, 2021, F45 Training…

Continue to read on GlobeNewswire

More to explorer